ArticleInternational journal of general medicine2026
Undiagnosed and Uncontrolled Hypertension in the Aseer Region, Saudi Arabia: A Ramadan Screening Study with Long-Term Trends (1990-2019) and Projections to 2027.
Article in International journal of general medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Community-based screening initiatives can facilitate early detection and link individuals to care. This study aimed to assess the prevalence of diagnosed and undiagnosed hypertension among adults in the Aseer region during Ramadan and contextualize these findings within national hypertension trends using World Health Organization (WHO) data from 1990 to 2019, with projections to 2027. Methods: A cross-sectional study was conducted from March 11-18, 2025, including 657 adults. Participants were classified as non-hypertensive, previously diagnosed, or having undiagnosed hypertension. Multinomial logistic regression was used to identify factors associated with hypertension status. Secondary analysis of WHO data was performed to examine national trends in hypertension prevalence and projection using autoregressive integrated moving average (ARIMA) and Poisson regression models. Results: Primary data revealed that 56.3% had undiagnosed hypertension (stage 1: 43.8% and stage 2: 56.2%) and 16.6% had a prior diagnosis (stage 1: 27.5% and stage 2: 62.4%). Older age (adjusted odds ratio (aOR): 17.17, 95% CI 4.80-61.42 for ages 55-64), male sex (aOR: 2.24, 95% CI 1.16-4.33), higher body mass index (aOR: 1.10, 95% CI 1.05-1.15), diabetes (aOR: 2.23, 95% CI 1.14-4.37), and self-reported dyslipidemia (aOR: 3.52, 95% CI 1.72-7.24) were independent predictors of diagnosed hypertension. Male sex and higher BMI were also significant predictors of undiagnosed hypertension. Between 1990-2019, secondary data revealed that females showed a significant decline in the prevalence of hypertension from 34.1% (95% CI: 21.5-49.2) to 30.2% (95% CI: 21.4-40.1) (APC: -0.58%), while prevalence among males increased from 34.4% (95% CI: 21.5-49.1) to 36.3% (95% CI: 26.6-46.7) (APC: 0.18%). Overall prevalence decreased slightly from 34.4% (95% CI: 24.9-45.1) to 34.0% (95% CI: 27.1-41.5) (APC: -0.4%). Forecasts for 2027 predicted a continued decline among females to 27.47% (95% prediction interval (PI): 26.42-28.51) (APC: -2.73%) and a modest increase among males to 36.82% (95%PI: 36.55-37.09) (APC: 1.4%), with the total prevalence projected to decrease slightly to 33.39% (95%PI: 32.64-34.14) (APC: -1.01%). Conclusion: Ramadan-based screening revealed a high burden of undiagnosed and uncontrolled hypertension. Along with forecasts of rising male but falling female prevalence, this underscores the urgent need for targeted community-based screening, education, and management to improve hypertension awareness and control.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.